Algeria vs Bhutan: Cause of death, by non-communicable diseases, ages 15-59
Algeria
62.8%
in 2021
Bhutan
63.2%
in 2021
Algeria rank
62nd
Bhutan rank
60th
Cause of death, by non-communicable diseases, ages 15-59 over time
- Algeria
- Bhutan
How they compare
Bhutan currently reports 63.2% against 62.8% in Algeria, a difference of 0.4%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Algeria ahead.
Algeria ranks 62nd and Bhutan ranks 60th of 185 countries.
Across the 3 decades both report, Algeria averaged higher in 2 and Bhutan in 1.
Head to head by decade
| Decade | Algeria | Bhutan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 59.5% | 54.5% | 5.0% | Algeria |
| 2010s | 68.5% | 58.8% | 9.7% | Algeria |
| 2020s | 54.5% | 63.1% | 8.6% | Bhutan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, Algeria or Bhutan?
- Bhutan, at 63.2% against 62.8% in Algeria as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59 between Algeria and Bhutan?
- 0.4%, with Bhutan ahead.
- How many years of comparable data are there for Algeria and Bhutan?
- 6 years are reported by both, from 2000 to 2021.
- How do Algeria and Bhutan rank globally for cause of death, by non-communicable diseases, ages 15-59?
- Algeria ranks 62nd and Bhutan ranks 60th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59 (% of total deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 15-59 due to non-communicable diseases divided by number of all deaths ages 15-59 expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.